Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies

Shield considering launch of Accrufer® in the USA – Loan facilities agreed

10 Dec 2020

Shield Therapeutics plc, provides an update on its plans to commercialise Accrufer® in the USA and its cash position. For full details click here.

Back to news